Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results
Background Programmed death ligand 1 (PD-L1) contributes to tumor immunosuppression
and is upregulated in aggressive meningiomas. We performed a phase II study of …
and is upregulated in aggressive meningiomas. We performed a phase II study of …
CDK 4/6 inhibitors for the treatment of meningioma
JS Young, RL Kidwell, A Zheng, AF Haddad… - Frontiers in …, 2022 - frontiersin.org
Meningiomas are the most common non-metastatic brain tumors, and although the majority
are relatively slow-growing and histologically benign, a subset of meningiomas are …
are relatively slow-growing and histologically benign, a subset of meningiomas are …
Radiotherapy and radiosurgery for meningiomas
Meningiomas comprise a histologically and clinically diverse set of tumors arising from the
meningothelial lining of the central nervous system. In the past decade, remarkable progress …
meningothelial lining of the central nervous system. In the past decade, remarkable progress …
Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index
Y Teranishi, A Okano, S Miyawaki, K Ohara… - Acta Neuropathologica …, 2022 - Springer
NF2 alteration is the most commonly–found genetic abnormality in meningiomas and is
known to initiate events for aggressive-type meningiomas. Whereas the prognosis of …
known to initiate events for aggressive-type meningiomas. Whereas the prognosis of …
Aggressive human MenG C meningiomas have a molecular counterpart in canines
AS Harmanci, B Boudreau, S Lau… - Acta …, 2024 - Springer
Meningiomas are not only the most common primary intracranial tumor in humans, but also
in household pets, such as cats and dogs [9, 10, 12]. We first reported that human …
in household pets, such as cats and dogs [9, 10, 12]. We first reported that human …
Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas
Background Meningioma is the most common primary intracranial tumor in adults. A subset
of these tumors recur and invade the brain, even after surgery and radiation, resulting in …
of these tumors recur and invade the brain, even after surgery and radiation, resulting in …
Chronic hyperglycemia and intracranial meningiomas
D Orešković, A Madero Pohlen, I Cvitković, JF Alen… - Bmc cancer, 2024 - Springer
Meningiomas are among the most common primary tumors of the central nervous system.
Previous research into the meningioma histological appearance, genetic markers …
Previous research into the meningioma histological appearance, genetic markers …
Radiotherapy and radiosurgery for meningiomas.
Meningiomas comprise a histologically and clinically diverse set of tumors arising from the
meningothelial lining of the central nervous system. In the past decade, remarkable progress …
meningothelial lining of the central nervous system. In the past decade, remarkable progress …
TERT promoter mutation and H3K27me3 trimethylation loss as focal molecular markers in meningioma aggressiveness
GJ Cello - 2022 - search.proquest.com
Biomarkers to identify high-grade meningiomas have finally been added to the recent 2021
edition of the World Health Organization (WHO) grading scheme. Among them, are the well …
edition of the World Health Organization (WHO) grading scheme. Among them, are the well …